| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ec226ec2fe2c4d6e72c83410327e54a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K135-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 |
| filingDate |
2021-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87bd9e0698704c7b4a588b05ce851383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2397a12de2bee06d18411f8eb9b604cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14087ee319bac4155fdc265dc3fd182b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_731f403737c97be2b486914e066f48ec |
| publicationDate |
2021-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113209146-A |
| titleOfInvention |
The use of the extract of Phytophthora vulgaris in the medicament for the prevention and/or treatment of uric acid nephropathy |
| abstract |
The present invention discloses the use of the extract of Radix vinifera in the preparation of medicines with the effect of lowering blood uric acid, blood creatinine and/or blood urea nitrogen. The dilute ethanolic extract of the present invention is proved by experiments that it has the effect of significantly reducing blood uric acid, blood creatinine and blood urea nitrogen, and at the same time, it has a remarkable effect in reducing renal inflammatory response, can be used for the treatment of uric acid nephropathy, and has the advantages of good clinical application prospects. |
| priorityDate |
2021-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |